Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy (FPHAF) Revenue
Annual & quarterly revenue history · segment & region breakdown
FPHAF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsFaron Pharmaceuticals Oy trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2024.
Revenue trend
2024 – 2012 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2024-12-31 | $0.00B | +$0.00B | — |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | +$0.00B | — |
| 2021-12-31 | $0.00B | +$0.00B | — |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | -$0.00B | -100.00% |
| 2018-12-31 | $0.00B | +$0.00B | +1170.90% |
| 2017-12-31 | $0.00B | -$0.00B | -99.87% |
| 2016-12-31 | $0.00B | +$0.00B | +121.73% |
| 2015-12-31 | $0.00B | -$0.00B | -42.60% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Faron Pharmaceuticals Oy receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Faron Pharmaceuticals Oy reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in EUR.
Data sourced from Faron Pharmaceuticals Oy's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
FPHAF revenue · 4 questionsFPHAF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2024.
▸ Source: FMP · Faron Pharmaceuticals Oy SEC filings · GAAP · Faron Pharmaceuticals Oy SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026